{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:23:01Z","timestamp":1787646181332,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Federal Do Cear\u00e1"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lanosterol 14-alpha demethylase (CYP51), encoded by the Erg11 gene, is a crucial enzyme in pathogenic fungi. It catalyzes the demethylation of lanosterol to ergosterol, a vital component of fungal cell membranes. Inhibition of CYP51 disrupts ergosterol biosynthesis, compromises membrane integrity, and inhibits fungal growth, making it a key target for antifungal therapy. In this study, we employed a comprehensive computational approach comprising molecular docking, drug-likeness analysis, dynamics simulations, pharmacophoric feature modeling, ADMET profiling, and pharmacokinetic (PK) simulations to identify novel CYP51 inhibitors from a library of 1,200 plant-derived metabolites. Of these, 211 compounds exhibited stronger binding affinities than voriconazole, a widely used antifungal agent. The top 10 metabolites showed strong interactions with key substrate recognition sites (SRS1, SRS2, SRS4, and SRS6) of CYP51. MD simulations of the top three candidates, Boeravinone D, Nimbidin, and 7-acetyl neotrichilenone, revealed stable binding conformations primarily driven by non-polar interactions, as confirmed by MM\/GBSA binding free energy calculations. Notably, Nimbidin exhibited the most favorable binding energetics, supported by Gibbs free energy and hydrogen bonding analyses. Principal component analysis (PCA) further indicated distinct and stable dynamic behaviors of the ligand\u2013protein complexes. Pharmacokinetic simulations suggested that Boeravinone D and Nimbidin may maintain prolonged plasma concentrations, indicating strong therapeutic potential. All three candidates showed favorable ADMET profiles, although 7-acetyl neotrichilenone may require optimization to improve solubility. These findings identify Boeravinone D, Nimbidin, and 7-acetyl neotrichilenone as promising CYP51 inhibitors. Further in vitro and in vivo studies are warranted to validate their antifungal efficacy and advance them as potential therapeutic agents.<\/jats:p>","DOI":"10.1007\/s12602-026-11178-5","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:28:28Z","timestamp":1787642908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Discovery of Novel CYP51 Inhibitors for Antifungal Therapy Against Aspergillus fumigatus"],"prefix":"10.1007","author":[{"given":"Shah Faisal","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taqdees Fatima","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnoor","family":"Zia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayyar Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venugopal","family":"Thiruvengadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Nishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled Fahmi","family":"Fawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-7102","authenticated-orcid":false,"given":"Mohibullah","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"11178_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","volume":"3","author":"F Bongomin","year":"2017","unstructured":"Bongomin F, Gago S, Oladele R, Denning D (2017) Global and multi-national prevalence of fungal diseases\u2014estimate precision. J Fungi 3:57. https:\/\/doi.org\/10.3390\/jof3040057","journal-title":"J Fungi"},{"key":"11178_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121312","volume":"14","author":"G Bouz","year":"2021","unstructured":"Bouz G, Dole\u017eal M (2021) Advances in antifungal drug development: an up-to-date mini review. Pharmaceuticals (Basel) 14:1312. https:\/\/doi.org\/10.3390\/ph14121312","journal-title":"Pharmaceuticals (Basel)"},{"key":"11178_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1126\/science.1222236","volume":"336","author":"GD Brown","year":"1979","unstructured":"Brown GD, Denning DW (1979) Levitz SM (2012) tackling human fungal infections. Science 336:647\u2013647. https:\/\/doi.org\/10.1126\/science.1222236","journal-title":"Science"},{"key":"11178_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0114-2022","volume":"31","author":"F Lamoth","year":"2022","unstructured":"Lamoth F, Calandra T (2022) Pulmonary aspergillosis: diagnosis and treatment. Eur Respir Rev 31:220114. https:\/\/doi.org\/10.1183\/16000617.0114-2022","journal-title":"Eur Respir Rev"},{"key":"11178_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jof9020131","volume":"9","author":"M-P Ledoux","year":"2023","unstructured":"Ledoux M-P, Herbrecht R (2023) Invasive pulmonary aspergillosis. J Fungi 9:131. https:\/\/doi.org\/10.3390\/jof9020131","journal-title":"J Fungi"},{"key":"11178_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/jof4030081","volume":"4","author":"E Bencurova","year":"2018","unstructured":"Bencurova E, Gupta SK, Sarukhanyan E, Dandekar T (2018) Identification of antifungal targets based on computer modeling. J Fungi 4:81. https:\/\/doi.org\/10.3390\/jof4030081","journal-title":"J Fungi"},{"key":"11178_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/jof7020067","volume":"7","author":"BC Monk","year":"2021","unstructured":"Monk BC, Keniya MV (2021) Roles for structural biology in the discovery of drugs and agrochemicals targeting sterol 14\u03b1-demethylases. J Fungi 7:67. https:\/\/doi.org\/10.3390\/jof7020067","journal-title":"J Fungi"},{"key":"11178_CR8","doi-asserted-by":"publisher","unstructured":"Zhang J, Li L, Lv Q et al (2019) The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors. Front Microbiol 10. https:\/\/doi.org\/10.3389\/fmicb.2019.00691","DOI":"10.3389\/fmicb.2019.00691"},{"key":"11178_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/1567-1364.12141","volume":"14","author":"L Klug","year":"2014","unstructured":"Klug L, Daum G (2014) Yeast lipid metabolism at a glance. FEMS Yeast Res 14:369\u2013388. https:\/\/doi.org\/10.1111\/1567-1364.12141","journal-title":"FEMS Yeast Res"},{"key":"11178_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.matpr.2023.09.075","volume":"103","author":"A Kumari","year":"2024","unstructured":"Kumari A, Singh A, Raghava M et al (2024) An approach of computer-aided drug design (CADD) tools for in silico assessment of various inhibitors of lanosterol-14\u03b1 demethylase. Mater Today Proc 103:415\u2013422. https:\/\/doi.org\/10.1016\/j.matpr.2023.09.075","journal-title":"Mater Today Proc"},{"key":"11178_CR11","doi-asserted-by":"publisher","DOI":"10.15586\/qas.v18i3.1625","author":"N Soundrarajan","year":"2026","unstructured":"Soundrarajan N, Somsundaram P, Dohun K et al (2026) Evaluation of protegrin-1 for meat preservation via peptide treatment and transgenic expression. Qual Assur Saf Crops Food. https:\/\/doi.org\/10.15586\/qas.v18i3.1625","journal-title":"Qual Assur Saf Crops Food"},{"key":"11178_CR12","unstructured":"Bansod S, Rai M (2008) Antifungal activity of essential oils from Indian medicinal plants against human pathogenic Aspergillus fumigatus and A. niger. World J Med Sci 3:81\u201388. http:\/\/idosi.org\/wjms\/3(2)08\/7.pdf"},{"key":"11178_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3923\/jms.2015.139.146","volume":"15","author":"DK Semwal","year":"2015","unstructured":"Semwal DK, Mishra SP, Chauhan A, Semwal RB (2015) Adverse health effects of tobacco and role of Ayurveda in their reduction. J Med Sci 15:139\u2013146. https:\/\/doi.org\/10.3923\/jms.2015.139.146","journal-title":"J Med Sci"},{"key":"11178_CR14","doi-asserted-by":"publisher","unstructured":"Shah M, Zia M, Ahmad I et al (2025) Computational analysis of Ayurvedic metabolites for potential treatment of drug-resistant Candida auris. Front Cell Infect Microbiol 15. https:\/\/doi.org\/10.3389\/fcimb.2025.1537872","DOI":"10.3389\/fcimb.2025.1537872"},{"key":"11178_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4103\/0974-8520.190699","volume":"36","author":"A Chauhan","year":"2015","unstructured":"Chauhan A, Semwal D, Mishra S, Semwal R (2015) Ayurvedic research and methodology: present status and future strategies. AYU (An Int Q J Res Ayurveda) 36:364. https:\/\/doi.org\/10.4103\/0974-8520.190699","journal-title":"AYU (An Int Q J Res Ayurveda)"},{"key":"11178_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.15586\/qas.v18i2.1629","volume":"18","author":"K Lin","year":"2026","unstructured":"Lin K, Dai J, Zhang R et al (2026) Antibacterial mechanism of geraniol against Staphylococcus aureus by targeting the cell membrane. Qual Assur Saf Crops Food 18:249\u2013267. https:\/\/doi.org\/10.15586\/qas.v18i2.1629","journal-title":"Qual Assur Saf Crops Food"},{"key":"11178_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2023.108435","volume":"121","author":"I Sama-ae","year":"2023","unstructured":"Sama-ae I, Pattaranggoon NC, Tedasen A (2023) In silico prediction of antifungal compounds from natural sources towards Lanosterol 14-alpha demethylase (CYP51) using molecular docking and molecular dynamic simulation. J Mol Graph Model 121:108435. https:\/\/doi.org\/10.1016\/j.jmgm.2023.108435","journal-title":"J Mol Graph Model"},{"key":"11178_CR18","doi-asserted-by":"publisher","unstructured":"Hassan A AOTMSMMASYAJ (2024) An In Silico Molecular Docking and ADMET Studies of Some GC-MS Analysed Compounds from Methanol Extract of Mitracapus hirtus. 1:21\u201335. https:\/\/doi.org\/10.34172\/jbp.2024.7","DOI":"10.34172\/jbp.2024.7"},{"key":"11178_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2174\/1570180818666211027114007","volume":"19","author":"N Rani","year":"2022","unstructured":"Rani N, Singh R, Kumar P (2022) Molecular modeling study for the evaluation of natural compounds as potential Lanosterol 14\u03b1-demethylase inhibitors. Lett Drug Des Discov 19:459\u2013471. https:\/\/doi.org\/10.2174\/1570180818666211027114007","journal-title":"Lett Drug Des Discov"},{"key":"11178_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s13237-022-00405-3","volume":"65","author":"N Nasim","year":"2022","unstructured":"Nasim N, Sandeep IS, Mohanty S (2022) Plant-derived natural products for drug discovery: current approaches and prospects. Nucleus 65:399\u2013411. https:\/\/doi.org\/10.1007\/s13237-022-00405-3","journal-title":"Nucleus"},{"key":"11178_CR21","doi-asserted-by":"publisher","unstructured":"Rahman MdM, Islam MdR, Akash S et al (2022) In silico investigation and potential therapeutic approaches of natural products for COVID-19: computer-aided drug design perspective. Front Cell Infect Microbiol 12. https:\/\/doi.org\/10.3389\/fcimb.2022.929430","DOI":"10.3389\/fcimb.2022.929430"},{"key":"11178_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s40203-025-00312-w","volume":"13","author":"KT Mesileya","year":"2025","unstructured":"Mesileya KT, Onyeka PC, Adaramola IM et al (2025) Tinospora cordifolia bioactive compounds as a novel sterol 14a-demethylase (CYP51) inhibitor: an in silico study. In Silico Pharmacol 13:28. https:\/\/doi.org\/10.1007\/s40203-025-00312-w","journal-title":"In Silico Pharmacol"},{"key":"11178_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12154-014-0121-1","volume":"7","author":"JE Parker","year":"2014","unstructured":"Parker JE, Warrilow AGS, Price CL et al (2014) Resistance to antifungals that target CYP51. J Chem Biol 7:143\u2013161. https:\/\/doi.org\/10.1007\/s12154-014-0121-1","journal-title":"J Chem Biol"},{"key":"11178_CR24","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1006\/rwfm.1999.1005","volume-title":"Encyclopedia of food microbiology","author":"MD Alur","year":"1999","unstructured":"Alur MD (1999) Metabolic pathways | nitrogen metabolism. Encyclopedia of food microbiology. Elsevier, pp 1288\u20131298"},{"key":"11178_CR25","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1345\/aph.19237","volume":"34","author":"JA Sabo","year":"2000","unstructured":"Sabo JA, Abdel-Rahman SM (2000) Voriconazole: a new triazole antifungal. Ann Pharmacother 34:1032\u20131043. https:\/\/doi.org\/10.1345\/aph.19237","journal-title":"Ann Pharmacother"},{"key":"11178_CR26","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1128\/AAC.41.11.2492","volume":"41","author":"H Sanati","year":"1997","unstructured":"Sanati H, Belanger P, Fratti R, Ghannoum M (1997) A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother 41:2492\u20132496. https:\/\/doi.org\/10.1128\/AAC.41.11.2492","journal-title":"Antimicrob Agents Chemother"},{"key":"11178_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2023.101385","volume":"42","author":"J Ahmed","year":"2023","unstructured":"Ahmed J, Raihan MM, Robin TB et al (2023) A computational approach to identify novel plant metabolites against Aspergillus fumigatus. Inform Med Unlocked 42:101385. https:\/\/doi.org\/10.1016\/j.imu.2023.101385","journal-title":"Inform Med Unlocked"},{"key":"11178_CR28","doi-asserted-by":"publisher","first-page":"23916","DOI":"10.1074\/jbc.M115.677310","volume":"290","author":"TY Hargrove","year":"2015","unstructured":"Hargrove TY, Wawrzak Z, Lamb DC et al (2015) Structure-functional characterization of cytochrome P450 sterol 14\u03b1-demethylase (CYP51B) from Aspergillus fumigatus and molecular basis for the development of antifungal drugs. J Biol Chem 290:23916\u201323934. https:\/\/doi.org\/10.1074\/jbc.M115.677310","journal-title":"J Biol Chem"},{"key":"11178_CR29","doi-asserted-by":"crossref","unstructured":"Lipinski C, Lombardo F, \u2026 BD-A drug delivery, 1997 U (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325","DOI":"10.1016\/S0169-409X(96)00423-1"},{"key":"11178_CR30","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y et al (2002) Molecular properties that influence the oral bioavailability of drug candidates. ACS Publ 45:2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"ACS Publ"},{"key":"11178_CR31","doi-asserted-by":"publisher","unstructured":"Ghose A, \u2026 VV-J of combinatorial, 1999 undefined (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of. ACS Publ 1:55\u201368. https:\/\/doi.org\/10.1021\/cc9800071","DOI":"10.1021\/cc9800071"},{"key":"11178_CR32","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"W Egan","year":"2000","unstructured":"Egan W, Merz K (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43:3867\u20133877. https:\/\/doi.org\/10.1021\/jm000292e","journal-title":"J Med Chem"},{"key":"11178_CR33","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/JM015507E","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44:1841\u20131846. https:\/\/doi.org\/10.1021\/JM015507E","journal-title":"J Med Chem"},{"key":"11178_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu PC, Afiukwa CA, Orji OU et al (2023) Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep 13:13398. https:\/\/doi.org\/10.1038\/s41598-023-40160-2","journal-title":"Sci Rep"},{"key":"11178_CR35","doi-asserted-by":"publisher","unstructured":"Shah M, Khan F, Ahmad I et al (2023) Computer-aided identification of Mycobacterium tuberculosis resuscitation-promoting factor B (RpfB) inhibitors from Gymnema sylvestre natural products. Front Pharmacol 14. https:\/\/doi.org\/10.3389\/fphar.2023.1325227","DOI":"10.3389\/fphar.2023.1325227"},{"key":"11178_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294769","volume":"19","author":"M Shah","year":"2024","unstructured":"Shah M, Yamin R, Ahmad I et al (2024) In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2. PLoS ONE 19:e0294769. https:\/\/doi.org\/10.1371\/journal.pone.0294769","journal-title":"PLoS ONE"},{"key":"11178_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4771745","author":"S Katuwal","year":"2023","unstructured":"Katuwal S, Upadhyaya SR, Marahatha R et al (2023) In silico study of coumarins: wedelolactone as a potential inhibitor of the spike protein of the SARS-CoV-2 variants. J Trop Med. https:\/\/doi.org\/10.1155\/2023\/4771745","journal-title":"J Trop Med"},{"key":"11178_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/B978-0-323-89775-4.00010-9","volume-title":"Bioinformatics","author":"A Tiwari","year":"2022","unstructured":"Tiwari A, Singh S (2022) Computational approaches in drug designing. Bioinformatics. Elsevier, pp 207\u2013217"},{"key":"11178_CR39","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1021\/acsomega.3c10351","volume":"9","author":"I Ahmad","year":"2024","unstructured":"Ahmad I, Khalid H, Perveen A et al (2024) Identification of novel quinolone and quinazoline alkaloids as phosphodiesterase 10A inhibitors for Parkinson\u2019s disease through a computational approach. ACS Omega 9:16262\u201316278. https:\/\/doi.org\/10.1021\/acsomega.3c10351","journal-title":"ACS Omega"},{"key":"11178_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2023.105465","volume":"17","author":"M Chalkha","year":"2024","unstructured":"Chalkha M, Chebbac K, Nour H et al (2024) In vitro and in silico evaluation of the antimicrobial and antioxidant activities of spiropyrazoline oxindole congeners. Arab J Chem 17:105465. https:\/\/doi.org\/10.1016\/j.arabjc.2023.105465","journal-title":"Arab J Chem"},{"key":"11178_CR41","doi-asserted-by":"publisher","unstructured":"Flores-Holgu\u00edn N, Frau J, Glossman-Mitnik D (2021) In silico pharmacokinetics, ADMET study and conceptual DFT analysis of two plant cyclopeptides isolated from rosaceae as a computational peptidology approach. Front Chem 9. https:\/\/doi.org\/10.3389\/fchem.2021.708364","DOI":"10.3389\/fchem.2021.708364"},{"key":"11178_CR42","doi-asserted-by":"publisher","unstructured":"Sarfraz A, Wara TU, Sheheryar et al (2023) Structural informatics approach for designing an epitope-based vaccine against the brain-eating Naegleria fowleri. Front Immunol 14:1\u201317. https:\/\/doi.org\/10.3389\/fimmu.2023.1284621","DOI":"10.3389\/fimmu.2023.1284621"},{"key":"11178_CR43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.2042-7158.2012.01534.x","volume":"64","author":"S Willmann","year":"2012","unstructured":"Willmann S, Thelen K, Lippert J (2012) Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim\u00ae. J Pharm Pharmacol 64:997\u20131007. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01534.x","journal-title":"J Pharm Pharmacol"},{"key":"11178_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/S146398150004245X","volume":"34","author":"HPS Makkar","year":"2006","unstructured":"Makkar HPS (2006) Chemical and biological assays for quantification of major plant secondary metabolites. BSAP Occas Publ 34:235\u2013249. https:\/\/doi.org\/10.1017\/S146398150004245X","journal-title":"BSAP Occas Publ"},{"key":"11178_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0021-9258(18)48462-1","volume":"267","author":"O Gotoh","year":"1992","unstructured":"Gotoh O (1992) Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem 267:83\u201390","journal-title":"J Biol Chem"},{"key":"11178_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbagen.2006.07.018","volume":"1770","author":"GI Lepesheva","year":"2007","unstructured":"Lepesheva GI, Waterman MR (2007) Sterol 14\u03b1-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochimica et Biophysica Acta (BBA) - Gen Sub 1770:467\u2013477. https:\/\/doi.org\/10.1016\/j.bbagen.2006.07.018","journal-title":"Biochimica et Biophysica Acta (BBA) - Gen Sub"},{"key":"11178_CR47","doi-asserted-by":"publisher","first-page":"25582","DOI":"10.1074\/jbc.M110.133215","volume":"285","author":"GI Lepesheva","year":"2010","unstructured":"Lepesheva GI, Hargrove TY, Anderson S et al (2010) Structural insights into inhibition of sterol 14\u03b1-demethylase in the human pathogen Trypanosoma cruzi. J Biol Chem 285:25582\u201325590. https:\/\/doi.org\/10.1074\/jbc.M110.133215","journal-title":"J Biol Chem"},{"key":"11178_CR48","doi-asserted-by":"publisher","unstructured":"Swati Gupta, Mishra HS, Tewari RK (2022) Nimb (Azadirachta Indica): validation of classical pharmacological properties through reverse pharmacology. Int J Ayurveda Pharma Res 46\u201351. https:\/\/doi.org\/10.47070\/ijapr.v10i9.2485","DOI":"10.47070\/ijapr.v10i9.2485"},{"key":"11178_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019628","volume":"6","author":"G Aviello","year":"2011","unstructured":"Aviello G, Canadanovic-Brunet JM, Milic N et al (2011) Potent antioxidant and genoprotective effects of Boeravinone G, a rotenoid isolated from Boerhaavia diffusa. PLoS ONE 6:e19628. https:\/\/doi.org\/10.1371\/journal.pone.0019628","journal-title":"PLoS ONE"},{"key":"11178_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11178_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.sbi.2017.12.008","volume":"48","author":"D Ochoa","year":"2018","unstructured":"Ochoa D, Bradley D, Beltrao P (2018) Evolution, dynamics and dysregulation of kinase signalling. Curr Opin Struct Biol 48:133\u2013140. https:\/\/doi.org\/10.1016\/j.sbi.2017.12.008","journal-title":"Curr Opin Struct Biol"},{"key":"11178_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27041409","volume":"27","author":"AM Awadelkareem","year":"2022","unstructured":"Awadelkareem AM, Al-Shammari E, Elkhalifa AEO et al (2022) Phytochemical and in silico ADME\/Tox analysis of Eruca sativa extract with antioxidant, antibacterial and anticancer potential against Caco-2 and HCT-116 colorectal carcinoma cell lines. Molecules 27:1409. https:\/\/doi.org\/10.3390\/molecules27041409","journal-title":"Molecules"},{"key":"11178_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190319","volume":"12","author":"K Bittermann","year":"2017","unstructured":"Bittermann K, Goss K-U (2017) Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: a mechanistic model. PLoS ONE 12:e0190319. https:\/\/doi.org\/10.1371\/journal.pone.0190319","journal-title":"PLoS ONE"},{"key":"11178_CR54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","volume":"455","author":"RL Juliano","year":"1976","unstructured":"Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta (BBA) - Biomembranes 455:152\u2013162. https:\/\/doi.org\/10.1016\/0005-2736(76)90160-7","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"11178_CR55","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/molecules22060871","volume":"22","author":"S Dewanjee","year":"2017","unstructured":"Dewanjee S, Dua T, Bhattacharjee N et al (2017) Natural products as alternative choices for P-glycoprotein (P-gp) inhibition. Molecules 22:871. https:\/\/doi.org\/10.3390\/molecules22060871","journal-title":"Molecules"},{"key":"11178_CR56","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci6003515","volume":"47","author":"T Hou","year":"2007","unstructured":"Hou T, Wang J, Zhang W, Xu X (2007) ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? J Chem Inf Model 47:460\u2013463. https:\/\/doi.org\/10.1021\/ci6003515","journal-title":"J Chem Inf Model"},{"key":"11178_CR57","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/jps.23146","volume":"101","author":"D Psimadas","year":"2012","unstructured":"Psimadas D, Georgoulias P, Valotassiou V, Loudos G (2012) Molecular nanomedicine towards cancer: 111In-labeled nanoparticles. J Pharm Sci 101:2271\u20132280. https:\/\/doi.org\/10.1002\/jps.23146","journal-title":"J Pharm Sci"},{"key":"11178_CR58","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3109\/03602539709037591","volume":"29","author":"S Rendic","year":"1997","unstructured":"Rendic S, Carlo FJD (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29:413\u2013580. https:\/\/doi.org\/10.3109\/03602539709037591","journal-title":"Drug Metab Rev"},{"key":"11178_CR59","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/jm701122q","volume":"51","author":"MP Gleeson","year":"2008","unstructured":"Gleeson MP (2008) Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 51:817\u2013834. https:\/\/doi.org\/10.1021\/jm701122q","journal-title":"J Med Chem"},{"key":"11178_CR60","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2018.05.019","volume":"700","author":"M Kudaibergenova","year":"2019","unstructured":"Kudaibergenova M, Perissinotti LL, Noskov SY (2019) Lipid roles in hERG function and interactions with drugs. Neurosci Lett 700:70\u201377. https:\/\/doi.org\/10.1016\/j.neulet.2018.05.019","journal-title":"Neurosci Lett"},{"key":"11178_CR61","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s00204-020-02763-w","volume":"94","author":"PA Walker","year":"2020","unstructured":"Walker PA, Ryder S, Lavado A et al (2020) The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development. Arch Toxicol 94:2559\u20132585. https:\/\/doi.org\/10.1007\/s00204-020-02763-w","journal-title":"Arch Toxicol"},{"key":"11178_CR62","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00044-017-2095-3","volume":"27","author":"RKP Tripathi","year":"2018","unstructured":"Tripathi RKP, Ayyannan SR (2018) Evaluation of 2-amino-6-nitrobenzothiazole derived hydrazones as acetylcholinesterase inhibitors: in vitro assays, molecular docking and theoretical ADMET prediction. Med Chem Res 27:709\u2013725. https:\/\/doi.org\/10.1007\/s00044-017-2095-3","journal-title":"Med Chem Res"},{"key":"11178_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/17460441.2018.1403419","volume":"13","author":"X Liu","year":"2018","unstructured":"Liu X, Shi D, Zhou S et al (2018) Molecular dynamics simulations and novel drug discovery. Expert Opin Drug Discov 13:23\u201337. https:\/\/doi.org\/10.1080\/17460441.2018.1403419","journal-title":"Expert Opin Drug Discov"},{"key":"11178_CR64","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.polymer.2005.02.107","volume":"46","author":"M Han","year":"2005","unstructured":"Han M, Chen P, Yang X (2005) Molecular dynamics simulation of PAMAM dendrimer in aqueous solution. Polymer (Guildf) 46:3481\u20133488. https:\/\/doi.org\/10.1016\/j.polymer.2005.02.107","journal-title":"Polymer (Guildf)"},{"key":"11178_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151575","volume":"756","author":"R Singh","year":"2025","unstructured":"Singh R, Purohit R (2025) Determining the effect of natural compounds on mutations of pyrazinamidase in multidrug-resistant tuberculosis: illuminating the dark tunnel. Biochem Biophys Res Commun 756:151575. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151575","journal-title":"Biochem Biophys Res Commun"},{"key":"11178_CR66","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"11178_CR67","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J et al (2019) End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev 119:9478\u20139508. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00055","journal-title":"Chem Rev"},{"key":"11178_CR68","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jmgm.2018.04.014","volume":"83","author":"S Mitra","year":"2018","unstructured":"Mitra S, Dash R (2018) Structural dynamics and quantum mechanical aspects of shikonin derivatives as CREBBP bromodomain inhibitors. J Mol Graph Model 83:42\u201352. https:\/\/doi.org\/10.1016\/j.jmgm.2018.04.014","journal-title":"J Mol Graph Model"},{"key":"11178_CR69","doi-asserted-by":"publisher","unstructured":"Stein SAM, Loccisano AE, Firestine SM, Evanseck JD (2006) Chapter 13 principal components analysis: a review of its application on molecular dynamics data. Annu Rep Comput Chem 2:233\u2013261. https:\/\/doi.org\/10.1016\/S1574-1400(06)02013-5","DOI":"10.1016\/S1574-1400(06)02013-5"},{"key":"11178_CR70","doi-asserted-by":"crossref","unstructured":"Tan Y, Hanson JA, Chu J, Yang H (2014) VIP MSM UBER WIP PCA Essential Protein Dynamics. Proteins 1084:51\u201362. http:\/\/link.springer.com\/10.1007\/978-1-62703-658-0","DOI":"10.1007\/978-1-62703-658-0_3"},{"key":"11178_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0165767","volume":"11","author":"CA Men\u00e9ndez","year":"2016","unstructured":"Men\u00e9ndez CA, Accordino SR, Gerbino DC, Appignanesi GA (2016) Hydrogen bond dynamic propensity studies for protein binding and drug design. PLoS ONE 11:1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0165767","journal-title":"PLoS ONE"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11178-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11178-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11178-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:28:29Z","timestamp":1787642909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11178-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":71,"alternative-id":["11178"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11178-5","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}